audit fees for last FY were $45k...for $11.25K for the quarter...listing fees would be approx $25k for the quarter...plenty of snouts in the trough
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling